de Haas; Sanne Lysbet

Patent Applications and Registrations

Patent applications and USPTO patent grants for de Haas; Sanne Lysbet.The latest application filed is for "responsiveness to angiogenesis inhibitors".

Company Profile

0.0.25

de Haas; Sanne Lysbet - Basel CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Responsiveness To Angiogenesis Inhibitors App 20170066822 - Carmeliet; Peter ; et al.	2017-03-09
Responsiveness To Angiogenesis Inhibitors App 20150004136 - Carmeliet; Peter ; et al.	2015-01-01
Blood Plasma Biomarkers For Bevacizumab Combination Therapies For Treatment Of Breast Cancer App 20140341893 - Andres; Herbert ; et al.	2014-11-20
Responsiveness To Angiogenesis Inhibitors App 20140294768 - de Haas; Sanne Lysbet ; et al.	2014-10-02
Method For Predicting Risk Of Hypertension Associated With Anti-angiogenesis Therapy App 20140294811 - de Haas; Sanne Lysbet ; et al.	2014-10-02
Method To Identify A Patient With An Increased Likelihood Of Responding To An Anti-cancer Therapy App 20140193397 - Andres; Herbert ; et al.	2014-07-10
Method To Identify A Pateint With An Increased Likelihood Of Responding To An Anti-cancer Therapy App 20140056874 - Andres; Herbert ; et al.	2014-02-27
Method To Identify A Pateint With An Increased Likelihood Of Responding To An Anti-cancer Therapy App 20140056875 - Andres; Herbert ; et al.	2014-02-27
Method To Identify A Pateint With An Increased Likelihood Of Responding To An Anti-cancer Therapy App 20140056876 - Andres; Herbert ; et al.	2014-02-27
Method To Identify A Patient With An Increased Likelihood Of Responding To An Anti-cancer Therapy App 20140023639 - Andres; Herbert ; et al.	2014-01-23
Method To Identify A Pateint With An Increased Likelihood Of Responding To An Anti-cancer Therapy App 20140023640 - Andres; Herbert ; et al.	2014-01-23
Method To Identify A Patient With An Increased Likelihood Of Responding To An Anti-cancer Therapy App 20140017231 - Andres; Herbert ; et al.	2014-01-16
Method To Identify A Patient With An Increased Likelihood Of Responding To An Anti-cancer Therapy App 20140017232 - Andres; Herbert ; et al.	2014-01-16
Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy App 20130344059 - Andres; Herbert ; et al.	2013-12-26
Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy App 20130344060 - Andres; Herbert ; et al.	2013-12-26
Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy App 20130336960 - Andres; Herbert ; et al.	2013-12-19
Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy App 20130336959 - Andres; Herbert ; et al.	2013-12-19
Methods And Compositions For Diagnostic Use In Cancer Patients App 20130315899 - De Haas; Sanne Lysbet ; et al.	2013-11-28
Method To Identify A Patient With An Increased Likelihood Of Responding To An Anti-cancer Therapy App 20130243758 - ANDRES; Herbert ; et al.	2013-09-19
Blood Plasma Biomarkers For Bevacizumab Combination Therapies For Treatment Of Breast Cancer App 20130183302 - DE HAAS; Sanne Lysbet ; et al.	2013-07-18
Blood Plasma Biomarkers For Bevacizumab Combination Therapies For Treatment Of Breast Cancer App 20130183303 - DE HAAS; Sanne Lysbet ; et al.	2013-07-18
Method To Identify A Patient With An Increased Likelihood Of Responding To An Anti-cancer Therapy App 20130183300 - ANDRES; HERBERT ; et al.	2013-07-18
Method To Identify A Patient With An Increased Likelihood Of Responding To An Anti-cancer Therapy App 20130171135 - ANDRES; Herbert ; et al.	2013-07-04
Blood Plasma Biomarkers For Bevacizumab Combination Therapies For Treatment Of Breast Cancer App 20130121999 - DE HAAS; Sanne Lysbet ; et al.	2013-05-16
Methods And Compositions For Diagnostic Use In Cancer Patients App 20110064732 - De Haas; Sanne Lysbet ; et al.	2011-03-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.